Tuesday, February 9, 2010, 11:23pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Lpath Inc. (LPTN.OB)

 At 14:34 EST: 0.96 USD  Up 0.06 (6.67%)  
MORE ON LPTN.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
LPATH INC (OTC BB:LPTN.OB) Delayed quote dataEdit
Last Trade: 0.96 USD
Trade Time: 2:34PM EST
Change: Up 0.06 (6.67%)
Prev Close: 0.90
Open: 0.90
Bid: 0.86 x 2500
Ask: 0.96 x 2500
1y Target Est: 3.50
Day's Range: 0.90 - 0.96
52wk Range: 0.40 - 1.47
Volume: 6,000
Avg Vol (3m): 15,830.2
Market Cap: 50.88M
P/E (ttm): 24.00
EPS (ttm): 0.04
Div & Yield: N/A (N/A%)
Lpath Inc. (LPTN.OB)
1d  5d  3m  6m  1y  2y  5y 
 Add LPTN.OB to Portfolio   Download Data

HEADLINES
• LPATH, INC Financials
EDGAR Online Financials (Wed, Nov 18)
• LPATH, INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
• Lpath to Present at the 2009 BIOCOM Investor Conference
Marketwire (Fri, Oct 23)
• Lpath Receives Grants From the National Institutes of Health and Publishes Key Paper in the Proceedings of the National Academy of Sciences
Marketwire (Tue, Oct 20)
• Lpath's iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients
Marketwire (Thu, Oct 8)
• LPATH, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh
EDGAR Online (Thu, Sep 24)
• Lpath and Merck Serono Extend ASONEP(TM) Collaboration
Marketwire (Thu, Sep 24)
• LPATH, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Aug 24)
• Lpath Achieves Merck Serono Milestone
Marketwire (Mon, Aug 24)
• Lpath Completes Enrollment of Patients in iSONEP(TM) Phase 1 Clinical Trial
Marketwire (Tue, Aug 18)
More Headlines for LPTN.OB...
ANALYST
EPS Est (next year) (Dec-09) : 0.02
EPS Est (in 2 years) (Dec-10) : -0.01
Avg Rec (current)*: 1.5
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutics to treat human diseases in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices